The goal is to deliver greater value to customers, doctors, and the broader healthcare ecosystem
Pete Pharma will leverage FABRX’s extensive foundation of scientific validation to deliver a commercially viable, pharmacy-ready solution in the US
Launches National IVD validation portal and protocols; highlights India’s strengthening health research ecosystem
Element5’s Agentic AI platform will be integrated with the HCHB EHR
CRISPR-based detection enables highly specific molecular recognition
Transformation to increase speed and redirect resources to growth opportunities within diabetes and obesity, aiming at reaching millions of untreated patients
Targeting a 10% reduction in energy and water consumption, and a 30% cut in carbon emissions across facilities by 2025
Vonvendi is the only recombinant Von Willebrand factor replacement therapy with approved indications in adults and children with VWD
Subscribe To Our Newsletter & Stay Updated
